DIMENSIONAL FUND ADVISORS LP

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 354204 AUSTIN, TX

Position in CRBP

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$1,282,690

+$653,030 QoQ

Shares Held

136,602

+76.6% QoQ

Ownership

0.737%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 86.04998462687222.ToString("F0")% Shared 12.484443858801482.ToString("F0")% None 1.465571514326291.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. CRBP ranks #137 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,282,690	136,602	+76.6%	Shares	Sole	2026-05-07
2025-12-31	$629,660	77,354	+381.2%	Shares	Sole	2026-02-12
2024-12-31	$189,685	16,075	0.0%	Shares	Sole	2025-02-13
2024-09-30	$331,627	16,075	0.0%	Shares	Sole	2024-11-07
2024-06-30	$727,393	16,075	0.0%	Shares	Sole	2024-08-09
2024-03-31	$630,783	16,075	-3.7%	Shares	Sole	2024-05-10
2023-12-31	$100,819	16,692	-42.9%	Shares	Sole	2024-02-07
2023-09-30	$196,963	29,223	-7.5%	Shares	Sole	2023-11-09
2023-06-30	$247,744	31,600	+131.0%	Shares	Sole	2023-08-09
2023-03-31	$99,460	13,681	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.